Nov 6, 2019
Pakistan Releases Draft Accelerated Drug Approval Guidelines
Pakistan Releases Draft Accelerated Drug Approval Guidelines
From the desk of DRAP- 05 November 2019
The Drug Regulatory Authority of Pakistan (DRAP) has published draft guidance on its priority review and accelerated approval processes alongside other guidance documents covering pharmacovigilance and post-registration variations.
The DRAP has created guidelines that stipulate two pathways with similar objectives. One pathway provides for priority…
View On WordPress
#accelerated pathway#approval guidelines#Asia#Asian pharmacovigilance#california#clinical research#clinical trial#dr nisha nair#drap#drug approval#drug development#drug registration guidance#drug regulatory authority of pakistan#indian subcontinent#medical writing#pacific biosafety group#pakistan#pharmaceutical industry#pharmaceutical quality assessment#pharmacovigilance#pharmacovigilance challenges#pharmacovigilance training#priority review#san jose#sanfranciscobayarea#SmPC#summary of product characteristics